Ipamorelin is a selective growth hormone secretagogue receptor agonist peptide studied for GH release with a relatively focused receptor profile compared with earlier GHRPs.
Ipamorelin is a selective growth hormone secretagogue receptor agonist peptide studied for GH release with a relatively focused receptor profile compared with earlier GHRPs.
Source & context
Biological / chemical source: Synthetic pentapeptide
Primary research or clinical context: Research compound (not an approved drug)
Receptor selectivity
Ipamorelin is frequently described as more selective than GHRP-2 or GHRP-6, with less reported impact on cortisol and prolactin in experimental contexts — a key reason for its research popularity.
FAQ about Ipamorelin
What is Ipamorelin?+
Ipamorelin is a selective growth hormone secretagogue receptor agonist peptide studied for GH release with a relatively focused receptor profile compared with earlier GHRPs.
Is Ipamorelin an approved medicine?+
Ipamorelin is discussed here as a research / educational topic. Research compound (not an approved drug). This is not medical advice.
What is the typical length of Ipamorelin?+
Ipamorelin is commonly described as approximately 5 amino acids (Research peptide).
Disclaimer: Educational content only. Not medical advice. Not instructions for human use. Research peptides and unapproved products may be restricted or illegal to market for human consumption in your jurisdiction. Consult qualified professionals and applicable law.
